235 related articles for article (PubMed ID: 17174763)
1. Lack of association between proliferative verrucous leukoplakia and human papillomavirus infection.
Bagan JV; Jimenez Y; Murillo J; Gavaldá C; Poveda R; Scully C; Alberola TM; Torres-Puente M; Pérez-Alonso M
J Oral Maxillofac Surg; 2007 Jan; 65(1):46-9. PubMed ID: 17174763
[TBL] [Abstract][Full Text] [Related]
2. Low prevalence of high risk genotypes of human papilloma virus in normal oral mucosa, oral leukoplakia and verrucous carcinoma.
Saghravanian N; Ghazvini K; Babakoohi S; Firooz A; Mohtasham N
Acta Odontol Scand; 2011 Nov; 69(6):406-9. PubMed ID: 21466259
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus as a risk factor in oral carcinogenesis: a study using in situ hybridization with signal amplification.
Acay R; Rezende N; Fontes A; Aburad A; Nunes F; Sousa S
Oral Microbiol Immunol; 2008 Aug; 23(4):271-4. PubMed ID: 18582325
[TBL] [Abstract][Full Text] [Related]
4. Genotypic determination by PCR-RFLP of human papillomavirus in normal oral mucosa, oral leukoplakia and oral squamous cell carcinoma samples in Madrid (Spain).
Llamas-Martínez S; Esparza-Gómez G; Campo-Trapero J; Cancela-Rodríguez P; Bascones-Martínez A; Moreno-López LA; García-Núñez JA; Cerero-Lapiedra R
Anticancer Res; 2008; 28(6A):3733-41. PubMed ID: 19189658
[TBL] [Abstract][Full Text] [Related]
5. Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array.
Luo CW; Roan CH; Liu CJ
Int J Oral Maxillofac Surg; 2007 Feb; 36(2):153-8. PubMed ID: 17110084
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997.
Miller CS; Johnstone BM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):622-35. PubMed ID: 11402272
[TBL] [Abstract][Full Text] [Related]
7. The prevalence and distribution of human papillomavirus genotypes in oral epithelial hyperplasia: proposal of a concept.
Varnai AD; Bollmann M; Bankfalvi A; Kovacs K; Heller H; Schmitt C; Volek J; Szendy M; Bollmann R; Hildenbrand R
J Oral Pathol Med; 2009 Feb; 38(2):181-7. PubMed ID: 19141061
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study.
Bagan JV; Jiménez Y; Murillo J; Poveda R; Díaz JM; Gavaldá C; Margaix M; Scully C; Alberola TM; Torres Puente M; Pérez Alonso M
Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E110-3. PubMed ID: 18223526
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive detection of HPV-DNA in paraffin sections of human oral carcinomas.
Koyama K; Uobe K; Tanaka A
J Oral Pathol Med; 2007 Jan; 36(1):18-24. PubMed ID: 17181737
[TBL] [Abstract][Full Text] [Related]
10. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples.
Majumder M; Indra D; Roy PD; Datta S; Ray JG; Panda CK; Roy B
J Oral Pathol Med; 2009 Feb; 38(2):174-80. PubMed ID: 18764855
[TBL] [Abstract][Full Text] [Related]
11. Proliferative verrucous leukoplakia: a concise update.
Bagan J; Scully C; Jimenez Y; Martorell M
Oral Dis; 2010 May; 16(4):328-32. PubMed ID: 20233330
[TBL] [Abstract][Full Text] [Related]
12. Biopsy vs. superficial scraping: detection of human papillomavirus 6, 11, 16, and 18 in potentially malignant and malignant oral lesions.
Furrer VE; Benitez MB; Furnes M; Lanfranchi HE; Modesti NM
J Oral Pathol Med; 2006 Jul; 35(6):338-44. PubMed ID: 16762014
[TBL] [Abstract][Full Text] [Related]
13. Correlation between c-Jun and human papillomavirus in oral premalignant and malignant lesions.
Acay RR; dos Santos E; de Sousa SO
Oral Oncol; 2008 Jul; 44(7):698-702. PubMed ID: 18061529
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus subtypes in oral lesions compared to healthy oral mucosa.
Kristoffersen AK; Enersen M; Kverndokk E; Sunde PT; Landin M; Solheim T; Olsen I; Grinde B
J Clin Virol; 2012 Apr; 53(4):364-6. PubMed ID: 22261124
[TBL] [Abstract][Full Text] [Related]
15. Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL.
Femiano F; Gombos F; Scully C
Int J Oral Maxillofac Surg; 2001 Aug; 30(4):318-22. PubMed ID: 11518355
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus in oral leukoplakia is no prognostic indicator of malignant transformation.
Yang SW; Lee YS; Chen TA; Wu CJ; Tsai CN
Cancer Epidemiol; 2009 Aug; 33(2):118-22. PubMed ID: 19679058
[TBL] [Abstract][Full Text] [Related]
17. Incidence of human papillomavirus infection in oral leukoplakia. Indications for a viral aetiology.
Cianfriglia F; Di Gregorio DA; Cianfriglia C; Marandino F; Perrone Donnorso R; Vocaturo A
J Exp Clin Cancer Res; 2006 Mar; 25(1):21-8. PubMed ID: 16761614
[TBL] [Abstract][Full Text] [Related]
18. Use of fuzzy neural networks in modeling relationships of HPV infection with apoptotic and proliferation markers in potentially malignant oral lesions.
Campisi G; Di Fede O; Giovannelli L; Capra G; Greco I; Calvino F; Maria Florena A; Lo Muzio L
Oral Oncol; 2005 Nov; 41(10):994-1004. PubMed ID: 16129653
[TBL] [Abstract][Full Text] [Related]
19. Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection.
Campisi G; Giovannelli L; Ammatuna P; Capra G; Colella G; Di Liberto C; Gandolfo S; Pentenero M; Carrozzo M; Serpico R; D'Angelo M
Oral Oncol; 2004 Sep; 40(8):835-40. PubMed ID: 15288840
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus infection in oral verrucous carcinoma: genotyping analysis and inverse correlation with p53 expression.
Fujita S; Senba M; Kumatori A; Hayashi T; Ikeda T; Toriyama K
Pathobiology; 2008; 75(4):257-64. PubMed ID: 18580072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
